Inverness Medical Innovations ( IMA) is a developer and manufacturer of medical diagnostic products for professionals and consumers.

The company's products focus on everything from fertility testing to infectious disease diagnostics, in addition to a line of vitamins and nutritional supplements.

And while the company's short ratio currently sits at a high 18.7%, Inverness Medical's novel business model could be the key to pushing ahead of competitors. Thanks to business exposure provided by an acquisition, the company plans to combine its diagnostic devices with health-management services in a way that maximizes the profitability of each. As the company continues to integrate its health-management acquisitions into its core diagnostic business, expect to see margins and overall profitability increase.

For the rest of this week's short-squeeze opportunities, including Virtual Radiologic ( VRAD) and Dr. Reddy's Laboratories ( RDY), check out the Health Stock Short Squeezes portfolio at Stockpickr.

And to find short-squeeze plays of your own, be sure to check out the Stockpickr Answers community for insights and investment ideas.

-- Written by Jonas Elmerraji in Baltimore.
At the time of publication, author had no positions in stocks mentioned.

Jonas Elmerraji is the editor and portfolio manager of the Rhino Stock Report, a free investment advisory that returned 15% in 2008. He is a contributor to numerous financial outlets, including Forbes and Investopedia, and has been featured in Investor's Business Daily, in Consumer's Digest and on

If you liked this article you might like

Kohl's Is Breaking Out After Teaming Up With Amazon: Chart

Walgreens Is Primed to Rally, With or Without Rite Aid

Tesla's Electric Beast Truck Will Roll Over and Crush Short Sellers

Even North Korea's Kim Jong Un Can't Stop This Epic S&P 500 Stock Rally

How to Invest in Unstoppable Gold Prices